Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
This study has been completed.
Study NCT00001790   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fever
Mycoses
Neutropenia
More general conditions related to this trial
Agranulocytosis
Body Temperature Changes
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Signs and Symptoms
Interventions listed in this trial
FK463
Additional drug interventions recognized in this trial
Micafungin
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services